![]() |
市場調査レポート
商品コード
1663315
腹部大動脈瘤 (AAA) 修復デバイス:市場洞察・競合情勢・市場予測 (~2032年)Abdominal Aortic Aneurysm (AAA) Repair Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 |
||||||
カスタマイズ可能
適宜更新あり
|
腹部大動脈瘤 (AAA) 修復デバイス:市場洞察・競合情勢・市場予測 (~2032年) |
出版日: 2025年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
腹部大動脈瘤 (AAA) 修復デバイスの市場規模は、2024年の27億9,875万米ドルから、予測期間中はCAGR 5.70%で推移し、2032年には43億3,597万米ドルの規模に成長すると予測されています。
腹部大動脈瘤 (AAA) 修復デバイスの需要は、主に高血圧、喫煙、高齢化、遺伝的素因など、大動脈瘤の開発に関連する危険因子の有病率の上昇によって牽引されています。さらに、血管内動脈瘤修復術 (EVAR) 技術の著しい進歩が、回復時間の短縮と手術リスクの低減を伴う低侵襲治療の選択肢を提供し、市場の成長をさらに後押ししています。早期発見が重視されるようになり、大動脈瘤スクリーニングプログラムの数が増加していることも市場拡大の主な要因となっています。スクリーニングの強化は早期診断とタイムリーな介入を可能にし、それによってAAA修復デバイスの採用を増加させています。危険因子の増加、EVARにおける継続的な技術革新、スクリーニングプログラムの急増などを総合すると、2025年から2032年までの予測期間中にAAA修復デバイス市場の大幅な成長が見込まれます。
市場力学:
世界保健機関 (WHO) の2023年のデータによると、世界の30~79歳の成人は推定12億8,000万人が高血圧であり、その大多数が低・中所得国に居住しています。憂慮すべきことに、高血圧成人の46%が自分の状態に気づいていません。高血圧は動脈壁圧を上昇させるため、時間の経過とともに大動脈を弱め、動脈瘤形成のリスクを高めます。食生活の乱れ、運動不足、ストレスなどの生活習慣要因によって高血圧の有病率が上昇を続ける中で、腹部大動脈瘤 (AAA) の発生率は増加すると予想されており、AAA修復デバイスの需要に拍車をかけています。
市場成長の主な促進要因は、血管内動脈瘤修復 (EVAR) 技術の進歩です。EVARは従来の開腹手術に代わる低侵襲手術を提供し、手術リスクの低減、回復時間の短縮、患者の快適性の向上といった大きなメリットをもたらします。このような利点により、EVARは高齢者や合併症を有する患者に特に適しており、AAA修復術の適応となる患者層が拡大しています。技術革新によってデバイスのデザイン、耐久性、手技の成功率が向上するにつれて、ステントグラフトのようなデバイスの需要は予測期間中に大幅に増加すると予想されます。
当レポートでは、世界の腹部大動脈瘤 (AAA) 修復デバイスの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。
Abdominal Aortic Aneurysm Repair Devices market by Type (Open Surgical Repair Devices and Endovascular Aneurysm Repair), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing risk factors associated with the development of aortic aneurysm and growing advancements in endovascular aneurysm repair technology.
The abdominal aortic aneurysm repair devices market was valued at USD 2,798.75 million in 2024, growing at a CAGR of 5.70% during the forecast period from 2025 to 2032 to reach USD 4,335.97 million by 2032. The demand for abdominal aortic aneurysm (AAA) repair devices is primarily driven by the rising prevalence of risk factors associated with aortic aneurysm development, including hypertension, smoking, aging populations, and genetic predispositions. Additionally, significant advancements in endovascular aneurysm repair (EVAR) technology offering minimally invasive treatment options with reduced recovery times and lower procedural risks are further propelling market growth. The increasing emphasis on early detection and the growing number of aortic aneurysm screening programs are also key contributors to market expansion. Enhanced screening efforts enable earlier diagnosis and timely intervention, thereby increasing the adoption of AAA repair devices. Collectively, the rising burden of risk factors, continuous technological innovations in EVAR, and the surge in screening programs are expected to drive substantial growth in the AAA repair devices market during the forecast period from 2025 to 2032.
Abdominal Aortic Aneurysm Repair Devices Market Dynamics:
According to the World Health Organization (WHO) 2023 data, an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension, with the majority residing in low- and middle-income countries. Alarmingly, 46% of hypertensive adults are unaware of their condition. Hypertension increases arterial wall pressure, which can weaken the aorta over time, thereby raising the risk of aneurysm formation. As hypertension prevalence continues to rise-driven by lifestyle factors such as poor diet, physical inactivity, and stress-the incidence of abdominal aortic aneurysm (AAA) is expected to grow, fueling demand for AAA repair devices.
A key driver of market growth is the advancement in endovascular aneurysm repair (EVAR) technology. EVAR provides a minimally invasive alternative to traditional open surgery, offering significant benefits such as reduced surgical risks, shorter recovery times, and enhanced patient comfort. These advantages make EVAR particularly suitable for elderly patients and those with comorbidities, thereby expanding the pool of eligible candidates for AAA repair. As technological innovations improve device design, durability, and procedural success rates, the demand for devices like stent grafts is anticipated to increase significantly during the forecast period.
Despite these growth drivers, the abdominal aortic aneurysm repair devices market faces certain challenges. High costs associated with AAA repair procedures and devices, along with stringent regulatory requirements for device approval, may hinder market expansion. Addressing these barriers through cost-effective solutions and streamlined regulatory processes will be crucial for sustaining market growth.
Abdominal Aortic Aneurysm Repair Devices Market Segment Analysis:
Abdominal Aortic Aneurysm Repair Devices market by Type (Open Surgical Repair Devices and Endovascular Aneurysm Repair), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the abdominal aortic aneurysm (AAA) repair devices market, the endovascular aneurysm repair (EVAR) category is projected to capture a significant revenue share in 2024. This growth is attributed to the numerous advantages and wide-ranging applications of EVAR over traditional open surgery.
EVAR is a minimally invasive procedure that involves placing stent grafts through small incisions in the groin using catheters, as opposed to open surgery, which requires a large abdominal incision and involves a longer recovery period. The less invasive nature of EVAR results in shorter hospital stays, reduced pain, fewer complications, and faster recovery times, making it the preferred choice for both patients and physicians.
A significant portion of AAA patients are elderly or have comorbid conditions that render them unsuitable for open surgery. EVAR's minimally invasive approach allows for the effective treatment of high-risk patients, thereby expanding the pool of eligible candidates for repair. This broader patient eligibility is a key factor driving the increased demand for EVAR compared to more invasive procedures.
Additionally, continuous advancements in stent graft technology such as improvements in flexibility, durability, and anatomical adaptability have enhanced the efficacy and safety of EVAR, making it accessible to a wider range of patients.
Given these factors, the EVAR category is expected to witness substantial growth, subsequently driving the overall expansion of the abdominal aortic aneurysm repair devices market during the forecast period.
North America is expected to dominate the overall abdominal aortic aneurysm repair devices market:
North America is projected to hold the largest share of the abdominal aortic aneurysm (AAA) repair devices market in 2024. This dominance is primarily driven by the high prevalence of risk factors associated with AAA, including rising hypertension rates and widespread tobacco use. Additionally, the region's advanced healthcare infrastructure, favorable market conditions for product launches and approvals, and increased patient awareness are key contributors to market growth.
According to the Centers for Disease Control and Prevention (CDC) 2024 data, approximately 49.2 million individuals, accounting for 19.8% of the total U.S. population, use tobacco products. Smoking introduces harmful chemicals such as nicotine and carbon monoxide into the bloodstream, damaging the endothelium (blood vessel lining) and weakening arterial walls, including the aorta. Over time, this damage can lead to a loss of elasticity in the aortic wall, increasing the risk of aneurysm formation. Consequently, the rising tobacco consumption in the region is expected to escalate AAA incidence, driving the demand for AAA repair devices in the United States and, subsequently, in North America during the forecast period.
The market is further bolstered by frequent product launches and regulatory approvals, which improve treatment options and expand patient eligibility. For example, in May 2024, the U.S. Food and Drug Administration (FDA) approved an expanded indication for the Gore Excluder conformable AAA endoprosthesis. The device is now approved for patients with an aortic neck angulation of <=90° and a minimum neck length of 10 mm, broadening its applicability and enhancing patient outcomes.
In summary, the increasing prevalence of AAA risk factors, robust healthcare infrastructure, supportive regulatory environment, and continuous technological advancements are key drivers fueling the growth of the AAA repair devices market in North America throughout the forecast period.
Abdominal Aortic Aneurysm Repair Devices Market Key Players:
Some of the key market players operating in the abdominal aortic aneurysm repair devices market include Cook Medical Inc., Medtronic, W. L. Gore & Associates, Inc., Cardinal Health, MicroPort Scientific Corporation, Terumo Corporation, Lombard Medical, Artivion, Inc., Endospan, Boston Scientific Corporation, Endologix LLC., and others.
Recent Developmental Activities in the Abdominal Aortic Aneurysm Repair Devices Market:
Key Takeaways From The Abdominal Aortic Aneurysm Repair Devices Market Report Study
Target Audience Who Can Be Benefited From This Abdominal Aortic Aneurysm Repair Devices Market Report Study
Frequently Asked Questions For The Abdominal Aortic Aneurysm Repair Devices Market: